首页> 外文期刊>The Tohoku Journal of Experimental Medicine >Increased reabsorption of alveolar edema fluid in the obese Zucker rat.
【24h】

Increased reabsorption of alveolar edema fluid in the obese Zucker rat.

机译:肥胖的Zucker大鼠肺泡水肿液的重吸收增加。

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetic patients have a decreased incidence of acute respiratory distress syndrome, but the mechanism responsible for the decreased incidence is uncertain. Reabsorption of alveolar edema fluid (alveolar fluid clearance) has been considered to play an important role in resolution of acute respiratory distress syndrome. However, little is known regarding alveolar fluid clearance in diabetes mellitus. Since the obese Zucker rat has been used as an experimental model for diabetes mellitus, we determined if alveolar fluid clearance increased in the obese Zucker rat. First, we compared alveolar fluid clearance in obese Zucker rats with that in lean Zucker rats and Sprague-Dawley (SD) rats. Then, we determined the role of sodium channel, Na,K-ATPase, and beta(2)-adrenoceptor, which drives alveolar fluid clearance, in obese Zucker rats. Alveolar fluid clearance was estimated by the progressive increase in alveolar albumin concentrations in the isolated lungs. We found that basal alveolar fluid clearance in obese Zucker rats was two-fold greater than that in lean Zucker rats and SD rats. The mRNA expression of alpha(1)-, beta(1)-Na, K-ATPase and beta(2)-adrenoceptor, but not mRNA expression of sodium channel, increased in obese Zucker rats. A selective beta(2)-agrenergic antagonist, but not a Na, K-ATPase inhibitor, specifically inhibited the increase in alveolar fluid clearance in obese Zucker rats. These results indicate that overexpression of beta(2)-adrenoceptor primarily increases basal alveolar fluid clearance in the obese Zucker rat. We speculate that the stimulation of alveolar fluid clearance ameliorates acute respiratory distress syndrome in patients with diabetes mellitus.
机译:糖尿病患者的急性呼吸窘迫综合征的发生率降低,但是降低发病率的机制尚不确定。肺泡水肿液的重吸收(肺泡液清除)被认为在解决急性呼吸窘迫综合征中起重要作用。然而,关于糖尿病患者的肺泡液清除知之甚少。由于肥胖的Zucker大鼠已被用作糖尿病的实验模型,因此我们确定肥胖Zucker大鼠的肺泡液清除率是否增加。首先,我们比较了肥胖Zucker大鼠与瘦Zucker大鼠和Sprague-Dawley(SD)大鼠的肺泡液清除率。然后,我们确定了肥胖的Zucker大鼠中钠通道,Na,K-ATPase和β(2)-肾上腺素能受体的作用,后者驱动肺泡液清除。通过分离的肺中肺泡白蛋白浓度的逐渐增加来估计肺泡液清除率。我们发现肥胖的Zucker大鼠的基础肺泡液清除率是瘦Zucker大鼠和SD大鼠的两倍。在肥胖的祖克大鼠中,α(1)-,β(1)-Na,K-ATPase和β(2)-肾上腺素受体的mRNA表达增加,但钠通道的mRNA表达却没有增加。选择性的β(2)-农业能源拮抗剂,但不是Na,K-ATPase抑制剂,可以特异性抑制肥胖的祖克大鼠的肺泡液清除率增加。这些结果表明,在肥胖的Zucker大鼠中,β(2)-肾上腺素受体的过度表达主要增加了基础肺泡液的清除率。我们推测,刺激肺泡液清除可改善糖尿病患者的急性呼吸窘迫综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号